Latest Insights, Interviews, News, and Resources.

HonuWorx goes subsea, offering game-changing, emission-reducing, economy-boosting tech.

HonuWorx uses ingenious tech to deliver zero-emission underwater operations and underpin the sustainable growth of clean energy sectors such as offshore wind sector.

UKI2S portfolio company, Presymptom Health, joins government pilot

To get AI-driven infection test into the NHS faster helping to tackle Anti-Microbial Resistance.

Improve efficiency, productivity and sustainability with Productive Machines

NetZero by 2030. Responsible investment. Environmental action. Social inclusion. Impact-first – that’s the mission. The driving force behind UKI2S.

Dinner is Served: Investment Predictions for 2024

By Douglas Hansen-Luke, Executive Chairman and Founder of Future Planet Capital (FPC) – Fund Manager of UKI2S

Oxford Space Systems’ £3M Funding Round, Supported by UK Ministry Of Defence contributed through UKI2S

Supported by UK Ministry Of Defence contributed through UKI2S. Oxford Space Systems announces the successful completion of a £3 million equity investment…

HALO’s novel X-ray diffraction technology will strengthen global security

Proving its X-ray diffraction technology (XRD) has the potential to enhance security, improve passenger facilitation, increase throughput, and reduce airport operational costs.

MitoRx Therapeutics Announces Close of Seed Extension Financing Round

To Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases.

Ingredients that don’t cost the earth

Building sustainability with engineering biology and AI…

Pencil Biosciences completes fundraise to develop novel gene editing and modulation technology

Pencil Biosciences is developing a fully synthetic gene modulation and editing platform that will have impact across a wide range of applications…

Laverock Therapeutics raises £13.5M to develop unique gene silencing platform for programmable advanced therapies

Laverock Therapeutics to commercialise the gene editing induced gene silencing (GEiGS®) platform for all human therapeutic applications.

£102m UK Innovation Science and Seed Fund prioritises Defence and Security Investment into UK-based startups

Machine Discovery Secures £4.5 Million to Deliver AI Tools For Semiconductor Design

Machine Discovery, a software company which uses machine learning technology to accelerate compute-intensive optimisation and simulation tasks, has secured £4.5-million of funding…

twig emerges from stealth with £3m in funding, to create a new bioengineering powerhouse in the UK

The new start-up will harness an AI-first approach to develop eco-friendly alternatives to everyday ingredients in consumer goods.

HALO X-ray Secures Investment to Accelerate its Disruptive X-ray Diffraction Technology for Security Screening and Contraband Detection

Investments in HALO X-ray Technologies will support regulatory approval of the first fieldable XRD system in checkpoint security…

UKI2S tops £100 million to provide UK economic boost

Investment in the UK Innovation & Science Seed Fund (UKI2S), a driving force in supporting early-stage innovation and high-impact businesses, now totals £102m

iFAST Diagnostics raise £2M to track and treat antibiotic-resistant bugs

Bacterial resistance to antibiotics is growing as a critical worldwide challenge, often stated as the next potential pandemic.

UKI2S 2022 year in review

It’s been an exciting year for UKI2S, with £37 million additional capital into the fund, expansion of our role to include investments into Defence and Security and Fusion…

CEO Spotlight: Iain Miller, CEO of PreSymptom Health

You develop an instinct through your career. Like an experienced driver, you start to see problems before they happen, you come to know that the car at the junction ahead might come out…

What makes an exceptional start-up leader?

Start ups may be founded by an individual with a grand vision but almost as soon as they raise the first pound a founder is joined by a nascent and fast growing team.

The role of seed funding in net zero solutions

Funding early-stage technology companies is critical for turning innovation and science into real world solutions, including those which will help us adapt to and combat climate change.

Tokamak Energy announces ST80-HTS advanced prototype on path to demonstrate grid ready fusion power in the early 2030s

Tokamak Energy today announces plans for its advanced prototype, ST80-HTS, which will be the world’s first high field spherical tokamak using high temperature superconducting…

CEO Spotlight: Gary Owen, CEO of Lineat Composites

As the world transitions towards hydrogen storage, there is increasing demand for storage vessels which are made from carbon fibre.

Silveray announces £2.2M seed round for ultra-efficient X-ray detector technology

Surrey University spin-out company raises £1.5M in a seed round led by UKI2S to commercialise a novel nano-material that makes X-ray detectors more efficient and promises a more viable route to wide area detector panels.

NAMSA acquires UK-based Perfectus Biomed Group to enhance customised microbiological solutions

NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced today its acquisition of Perfectus Biomed Group…